
The Autopsy of Jane Doe
2016
Insufficient evidence
We did not find enough credible, independent evidence to publish a numeric cash-grab score. Unrated is more honest than a guess.
What counts as a cash grab?
Commercial extraction prioritized over meaningful consumer or creative value. Profit, popularity, adaptations, sequels, remakes, high budgets, and normal marketing do not count by themselves.
Why?
The Autopsy of Jane Doe is a 2016 supernatural horror film directed by André Ørvedal that premiered at TIFF and played a limited IFC Midnight theatrical run with day-and-date VOD before home video. Reporting and reviews consistently highlight low-budget practical effects, a focused two-actor performance, and strong directorial craft, while box office records show modest commercial returns near $6 million. I found no credible reporting of predatory monetization, rushed deceptive release tactics, franchise exploitation, or price gouging tied to this title.
- Contemporary reviews and festival coverage praise craft, practical effects, and performances, indicating substantive creative effort.
- Budget and production notes describe detailed prosthetic and practical corpse work, consistent with investment in craft over reuse.
- Distribution was a standard indie pattern, limited theatrical plus day-and-date VOD via IFC Midnight and subsequent home video.
View full breakdownHide full breakdown
Score factors
| Direction | Factor | Evidence | Impact |
|---|---|---|---|
| Against | Practical effects and prosthetics | Detailed reports on the film note full-body silicone casts, multiple internal organ builds, and surgically accurate prosthetics used for the Jane Doe effects.[1] | -18 |
| Against | Critical praise for direction and performances | Major critics praised Ørvedal's direction and the film's tension and performances, describing it as effective and creatively executed rather than cheaply assembled.[5][6][7] | -8 |
| Against | IFC Midnight limited theatrical and day-and-date VOD | The film followed a common indie release path, premiering at TIFF then receiving a limited theatrical release and simultaneous VOD through IFC Midnight rather than a premium exploitative rollout.[2][3][4] | -9 |
Confidence: Low · No source-backed commercial-extraction signal was found. · Researched 2026-09-28
Sources reviewed
- [1]saturation.io
- [2]en.wikipedia.org
- [3]www.boxofficemojo.com
- [4]media.fetch.fm
- [5]www.rogerebert.com
- [6]bloody-disgusting.com
- [7]www.theguardian.com
- [8]www.rottentomatoes.com
- [9]festivalreviews.org
- [10]www.rottentomatoes.com